BD acquires digital at-home test maker Scanwell Health

[Image from BD/Scanwell]

BD (NYSE:BDX) announced today that it completed the acquisition of smartphone-enabled, at-home medical test developer Scanwell Health.

Financial terms for the transaction were not disclosed. BD expects the acquisition to be immaterial to its fiscal 2022 results, with Scanwell’s financial results set to be reported under BD’s integrated diagnostic solutions business within the life sciences segment.

Franklin Lakes, New Jersey-based BD collaborated with Scanwell in the past on COVID-19 testing, announcing in February that it was working with Scanwell Health to offer its mobile app to pair with the BD Veritor at-home COVID-19 test, which uses a smartphone camera and app to capture and interpret results.

Scanwell will become the digital platform on which BD plans to develop at-home diagnostic tests for a range of infectious diseases, including COVID-19, influenza A+B, group A strep and more, according to a news release.<…

Read more
  • 0

DTW Podcast: Geoff Martha updates Medtronic’s new course; AJAX CEO Duke Rohlen is funding innovation differently

Medtronic CEO Geoff Martha and Ajax CEO Duke Rohlen share insights and wisdom on this episode of the podcast.

Less than a year into his role as CEO, Geoff Martha and the Medtronic leadership has overseen a significant reorganization of medtech’s largest player.

In our closing keynote conversation, Martha says the company is clearing a minor COVID-19 bump and sees open road for the company to continue to grab share from competitors.

Martha details what products are gaining the most traction while also identifying those that still have some ground to gain.

We also discuss: When it may bring its renal denervation project to the FDA Why Hugo the surgical robot will be worth the wait (and why development has taken more than a decade) Whether or not Medtronic will collaborate more with private equity firms, early-stage incubators and maybe even SPACs? What will the company’s acquisition strategy look like in 2021. And why. Why the price-cutting for drug-eluting …
Read more
  • 0

BD, Scanwell Health collaborating on smartphone-enabled, home COVID-19 rapid test

Becton Dickinson (NYSE:BDX) announced today that it is collaborating with Scanwell Health to create an at-home rapid COVID-19 test.

Scanwell Health, a developer of smartphone-enabled at-home medical tests, will offer its mobile app to pair with a BD antigen test for SARS-CoV-2, the virus causing COVID-19, according to a news release.

As part of the collaboration, Franklin Lakes, N.J.-based BD intends to produce a lateral flow antigen test to pair with the Scanwell app, which will give step-by-step instructions for collecting and transferring a nasal swab sample while the device camera will analyze and interpret results.

Once collected, the test result will be displayed on the screen. The companies are planning to develop functionality to assist in automated reporting to public health agencies, too, as they seek to offer an efficient and scalable rapid antigen home testing solution.

“Testing at home before going out into the public is a criti…

Read more
  • 0